In silico drug design strategies for discovering novel tuberculosis therapeutics.

Christian S Carnero Canales Aline Renata Pavan Jean Leandro Dos Santos Fernando Rogério Pavan

Published in: Expert opinion on drug discovery (2024)

These in silico methods have not only streamlined the drug discovery process but also opened up new horizons for finding novel drug candidates and repositioning existing ones. The continued advancements in these fields hold great promise for more efficient, ethical, and successful drug development in the future.

Keyphrases

drug discovery
molecular docking
adverse drug
mycobacterium tuberculosis
small molecule
drug induced
current status
emergency department
pulmonary tuberculosis
machine learning
hepatitis c virus
deep learning
electronic health record